biotech supply chain innovation

Biotechnology companies entering 2026 are confronting a supply chain environment fundamentally different from the one that shaped the sector a decade ago. Clinical pipelines are expanding into advanced modalities such as cell therapy, mRNA platforms, and personalized biologics, each requiring precise material sourcing, temperature control, and regulatory traceability. As a result, supply chain strategy has … Read more